Monday, December 20, 2021 4:30:19 PM
Mon, December 20, 2021, 11:02 AM
In this article:
GBT
+2.32%
Explore the topics mentioned in this article
Global Blood Therapeutics, Inc. GBT announced that the FDA has granted accelerated approval to its supplemental new drug application (“sNDA”) for Oxbryta (voxelotor) to treat sickle cell disease (“SCD”) in children aged four to less than 12 years.
The regulatory body also approved the new drug application (“NDA”) for Oxbryta tablets for oral suspension – a new dispersible, once-daily tablet dosage for patients aged four to less than 12 years, as well as for older patients who have difficulty swallowing whole tablets.
Oxbryta is currently approved by the FDA as an oral, once-daily treatment for SCD in patients aged 12 years or above.
The FDA nod for the sNDA was based on data from the phase IIa HOPE-KIDS 1 study, which evaluated Oxbryta in the given patient population. Data from the same showed that weight-based treatment with the dispersible tablet formulation of Oxbryta led to rapid and sustained improvements in hemoglobin. Concurrent reduction of hemolysis or red blood cell destruction was also demonstrated in the study.
Shares of Global Blood have plunged 29.5% so far this year compared with industry’s decrease of 19%.
Recent GBT News
- GROUPE BMTC INC. ANNONCE L'ACQUISITION D'UN CENTRE DE DISTRIBUTION À TERREBONNE AFIN DE GÉNÉRER DES REVENUS LOCATIFS À LONG TERME • PR Newswire (Canada) • 04/15/2024 11:30:00 PM
- BMTC GROUP INC. ANNOUNCES THE ACQUISITION OF A DISTRIBUTION CENTER TO GENERATE LONG-TERM RENTAL INCOME • PR Newswire (Canada) • 04/15/2024 11:30:00 PM
- GROUPE BMTC INC. ANNONCE LE RENOUVELLEMENT DE SON OFFRE DE RACHAT DANS LE COURS NORMAL DES ACTIVITÉS VISANT SES ACTIONS ORDINAIRES • PR Newswire (Canada) • 04/10/2024 11:30:00 PM
- BMTC GROUP INC. ANNOUNCES THE RENEWAL OF ITS NORMAL COURSE ISSUER BID TO ACQUIRE COMMON SHARES • PR Newswire (Canada) • 04/10/2024 11:30:00 PM
- GROUPE BMTC INC. ANNONCE SES RÉSULTATS FINANCIERS POUR LA PÉRIODE DE NEUF MOIS TERMINÉE LE 31 OCTOBRE 2023 • PR Newswire (Canada) • 12/12/2023 12:30:00 AM
- BMTC GROUP INC. ANNOUNCES FINANCIAL RESULTS FOR THE NINE MONTH PERIOD ENDED OCTOBER 31st, 2023 • PR Newswire (Canada) • 12/12/2023 12:30:00 AM
- BMTC GROUP INC. ANNOUNCES FINANCIAL RESULTS FOR THE SEMESTER ENDED JULY 31st, 2023 • PR Newswire (Canada) • 09/07/2023 11:30:00 PM
- GROUPE BMTC INC. ANNONCE SES RÉSULTATS FINANCIERS POUR LE SEMESTRE TERMINÉ LE 31 JUILLET 2023 • PR Newswire (Canada) • 09/07/2023 11:30:00 PM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Mawson Finland Provides Update on Exploration Activities at Rajapalot • MFL • Aug 21, 2024 9:06 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM